India Obesity
- All
- News
- Videos
- Web Stories
-
Body Image, Weight, Chronic Disease: Doctor Explains Evolving Patterns In Indian Women's Health
Medical experts now diagnose conditions which were once midlife issues in women who are currently 30 or 20 years old.
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
1 In 8 Teens In Kolkata Schools Obese, Study Flags Lifestyle Risks
A study of Kolkata schools has found that one in eight adolescents aged 12-16 is obese, highlighting a growing childhood obesity crisis.
-
Children Don't Always Look' Obese: Here's What You Might Miss
Childhood obesity isn't always visible hidden risks demand early detection and healthy habits.
-
World Obesity Day 2026: India's Child Obesity Numbers Soar, Ranks 2nd Worldwide
India ranks second globally for children living with overweight and obesity, warns the World Obesity Atlas 2026. With 41 million affected and sharp rises projected by 2040, experts urge urgent policy action, including sugar taxes and marketing curbs.
-
World Obesity Day 2026: Date, Significance And Why It Matters For India
In India, where obesity rates are rising rapidly, this day serves as an important reminder to prioritise healthy lifestyles and seek medical support when needed.
-
World Protein Day 2026: How Much Protein Do You Need As You Age?
The exact amount of protein needed as you age depends on your body's ability to process and absorb it. Here are the reasons why you need protein to function efficiently as you age.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
Body Image, Weight, Chronic Disease: Doctor Explains Evolving Patterns In Indian Women's Health
Medical experts now diagnose conditions which were once midlife issues in women who are currently 30 or 20 years old.
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
1 In 8 Teens In Kolkata Schools Obese, Study Flags Lifestyle Risks
A study of Kolkata schools has found that one in eight adolescents aged 12-16 is obese, highlighting a growing childhood obesity crisis.
-
Children Don't Always Look' Obese: Here's What You Might Miss
Childhood obesity isn't always visible hidden risks demand early detection and healthy habits.
-
World Obesity Day 2026: India's Child Obesity Numbers Soar, Ranks 2nd Worldwide
India ranks second globally for children living with overweight and obesity, warns the World Obesity Atlas 2026. With 41 million affected and sharp rises projected by 2040, experts urge urgent policy action, including sugar taxes and marketing curbs.
-
World Obesity Day 2026: Date, Significance And Why It Matters For India
In India, where obesity rates are rising rapidly, this day serves as an important reminder to prioritise healthy lifestyles and seek medical support when needed.
-
World Protein Day 2026: How Much Protein Do You Need As You Age?
The exact amount of protein needed as you age depends on your body's ability to process and absorb it. Here are the reasons why you need protein to function efficiently as you age.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
